Prospective, Randomized Clinical Trial Comparing Early Versus Delayed Postoperative Mobilization After Arthroscopic Rotator Cuff Tear Reapair. (RAPIDREHAB)

July 1, 2020 updated by: Borja Alcobía-Díaz MD, PhD

Arthroscopic suture for complete and partial >50% thickness Rotator Cuff Tears (RCT) is the gold standard. However, there is no evidence of superiority of delayed postoperative mobilization protocols versus early ones, in terms of ROM, pain, quality of life and complications in last review published in 2019 by AAOS. Although, excessive immobilization can lead into stiffness, neuropathic pain or adhesive capsulitis. All of these are complications which can diminish patient quality of life or prolong their return to work or sports activities.

This is an experimental, prospective, non-blind, comparative, randomized clinical trial, between two options of treatment. On one treatment branch, we will continue applying our standard postoperative 4 weeks immobilization rehabilitation program with a sling in adduction and internal rotation. On the other treatment branch, we will start passive mobilization during second week after surgery, including controlled external rotation movements. All recruited patients will be followed-up during 12 months.

Our main objective is to compare differences in terms of functionality (using ASES scale). Secondary objectives are to compare differences in terms of ROM, functionality (using CMS and UCLA scales), pain (using VAS score), need of analgesic drugs, quality of life (using EQ-5D scale), return to previous work and sports activities, patient adhesion to protocol, complications and MRI rotator cuff retear ratio at 12 months follow-up.

After this study, we hope to develop a new postoperative mobilization protocol for patients. This protocol will be focused on timing, and self-administrated exercises in order to involve patients in their recovery, in the fastest and safest way for them.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: Less tan 70 years old.
  • Sex: Male or Female.
  • Treatment: Arthroscopic RCT suture.
  • RCT type: Degenerative, total or partial >50% thickness, less than 3 cm length tear.
  • MRI Tear Classification: Patté's in coronal view I or II, Goutalier's <2, Fukuda's <2 and Seebauer´s 1A maximum.

Exclusion Criteria:

  • Not meet the inclusion criteria.
  • Previous surgical procedure in affected shoulder.
  • Have been treated with 2 or more glucocorticoid injections in last year.
  • High anesthetic risk.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard rehabilitation program
Standard postoperative 4 weeks immobilization rehabilitation program with a sling in adduction and internal rotation
Standard rehabilitation will start 4 weeks after surgery according to the standard of cre
Experimental: Early rehabilitation program
Early rehabilitation program will start passive mobilization during second week after surgery, including controlled external rotation movements
Early rehabilitation program will start 2 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functionality
Time Frame: 12 months after surgery
Functionality assessment using ASES scale
12 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functionality-Constant-Murley scale
Time Frame: 12 months after surgery
Functionality assessment using Constant-Murley scale
12 months after surgery
Functionality-UCLA
Time Frame: 12 months after surgery
Functionality assessment using UCLA scale
12 months after surgery
Pain
Time Frame: 12 months after surgery
Pain estimation according to visual analogic scale
12 months after surgery
Range of motion
Time Frame: 12 months after surgery
Range of motion measured in degrees of a circle
12 months after surgery
Analgesic use
Time Frame: 12 months after surgery
Need of analgesic drugs during the follow up period
12 months after surgery
Quality of life
Time Frame: 12 months after surgery
Quality of life according to EQ-5D scale
12 months after surgery
Complications
Time Frame: 12 months after surgery
Complications related to the surgery or rehabilitation
12 months after surgery
MRI rotator cuff retear ratio
Time Frame: 12 months after surgery
MRI rotator cuff retear ratio determinate by MRI
12 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Borja Alcobía Díaz, MD PhD, Hospital Clinico San Carlos

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2020

Primary Completion (Anticipated)

September 30, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

July 1, 2020

First Submitted That Met QC Criteria

July 1, 2020

First Posted (Actual)

July 7, 2020

Study Record Updates

Last Update Posted (Actual)

July 7, 2020

Last Update Submitted That Met QC Criteria

July 1, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • RAPIDREHAB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tear Repair

Clinical Trials on Standard rehabilitation program

3
Subscribe